1. PO.6.132 A phase 2b study of afimetoran (BMS-986256) in patients with active systemic lupus erythematosus (SLE): optimization of a lupus clinical trial design. (27th September 2022) Authors: Ranganathan, U; Merrill, JT; Crow, MK; Delev, N; Banerjee, S; Grasela, D; Harrison, M; Shen, Y; Culotta, E; Greenberg, S; Shah, V Journal: Lupus science & medicine Issue: Volume 9(2022)Supplement 2 Page Start: A100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗